I am approaching a year on treatment in August and have responded well (CHR in 1.5 mos, MMR in 3 mos). I am reviewing my treatment to date and note that my monitoring is different than the NCCN guidelines. My oncologist specializes in AML and CML and is very data driven in her treatment plans. I will ask at my my next appointment, but I note that I have primarily been monitored by PCR and cbc. I note that the NCCN guidelines were last updated in 2011. The question is whether my monitoring is more current than the guidelines? I have responded well enough (so far) that the question may be moot.
It should be noted that I have been verbal about my hope to never have another bone marrow biopsy/aspirate, so I may have skewed the process.